EFA Supplementation in Children with Inattention, Hyperactivity, and other Disruptive Behaviors

Lipids

Volumn 38, Issue 10, 2003, Pages 1007-1021

  Stevens, Laura ^a   Zhang, Wen ^a   Peck, Louise ^c   Kuczek, Thomas ^b   Grevstad, Nels ^b   Mahon, Anne ^a   Zentall, Sydney S ^a   Arnold, L Eugene ^d   Burgess, John R ^a  

^a PURDUE UNIVERSITY   (United States)

^b PURDUE UNIVERSITY   (United States)

^c WASHINGTON STATE UNIVERSITY   (United States)

^d OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD; CELLS; DISEASES; PHOSPHOLIPIDS; SKIN; VEGETABLE OILS; VITAMINS;

BEHAVIOURAL DISORDERS;

FATTY ACIDS;

ALPHA TOCOPHEROL; ARACHIDONIC ACID; ESSENTIAL FATTY ACID; OLIVE OIL; PHOSPHOLIPID; POLYUNSATURATED FATTY ACID;

ADOLESCENT; ARTICLE; ATTENTION DEFICIT DISORDER; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIET SUPPLEMENTATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PARENT; PHOSPHOLIPID BLOOD LEVEL; PRESCHOOL CHILD; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; STATISTICAL SIGNIFICANCE;

EID: 0345255862     PISSN: 00244201     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11745-006-1155-0     Document Type: Article

References (100)

1. american Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders, 4th edn., APA, Washington, DC.
2. Arnold, L.E. (2000) Contemporary Diagnosis and Management of ADHD, Handbooks in Health Care Co., Newton, PA.
3. Barkley, R.A. (1998) Attention-Deficit Hyperactivity Disorder: A Handbook of Diagnosis and Treatment, Guilford Press, New York.
4. Castellanos, F.X. (1997) Toward a Pathophysiology of Attention-Deficit/Hyperactivity Disorder, Clin. Pediatr. (Philadelphia) 36, 381-393.
5. Taylor, E. (1999) Developmental Neuropsychopathology of Attention Deficit and Impulsiveness, Dev. Psychopathol. 11, 607-628.
6. Faraone, S.V., and Biederman, J. (1998) Neurobiology of Attention-Deficit Hyperactivity Disorder, Biol. Psychiatry 44, 951-958.
7. Jensen, P.S. (2000) ADHD: Current Concepts on Etiology, Pathophysiology, and Neurobiology, Child Adolesc. Psychiatr. Clin. N. Am. 9, 557-572, vii-viii.
8. Arnold, L. (1999) Treatment Alternatives for Attention-Deficit/Hyperactivity Disorder (ADHD), J. Atten. Disord. 3, 30-48.
9. Hartsough, C.S., and Lambert, N.M. (1985) Medical Factors in Hyperactive and Normal Children: Prenatal, Developmental, and Health History Findings, Am. J. Orthopsychiatry 55, 190-201.
10. Stewart, M.A., Pitts, F.N., Jr., Craig, A.G., and Dieruf, W. (1966) The Hyperactive Child Syndrome, Am. J. Orthopsychiatry 36, 861-867.
11. Leibson, C.L., Katusic, S.K., Barbaresi, W.J., Ransom, J., and O'Brien, P.C. (2001) Use and Costs of Medical Care for Children and Adolescents With and Without Attention-Deficit/Hyperactivity Disorder, JAMA 285, 60-66.
12. Burr, G., and Burr, M. (1930) On the Nature and Role of the Fatty Acids Essential in Nutrition, J. Biol. Chem. 86, 587-621.
13. Hansen, A., Haggard, M., Boelsche, A., Adam, D., and Wiese, H. (1958) Essential Fatty Acids in Infant Nutrition. III. Clinical Manifestations of Linoleic Acid Deficiency, J. Nutr. 66, 565-576.
14. Galland, L. (1986) Increased Requirements for Essential Fatty Acids in Atopic Individuals: A Review with Clinical Descriptions, J. Am. Coll. Nutr. 5, 213-228.
15. Lindskov, R., and Holmer, G. (1992) Polyunsaturated Fatty Acids in Plasma, Red Blood Cells and Mononuclear Cell Phospholipids of Patients with Atopic Dermatitis, Allergy 47, 517-521.
16. Wright, S., and Burton, J.L. (1982) Oral Evening-Primrose-Seed Oil Improves Atopic Eczema, Lancet 2, 1120-1122.
17. Manku, M.S., Horrobin, D.F., Morse, N.L., Wright, S., and Burton, J.L. (1984) Essential Fatty Acids in the Plasma Phospholipids of Patients with Atopic Eczema, Br. J. Dermatol. 110, 643-648.
18. Manku, M.S., Horrobin, D.F., Morse, N., Kyte, V., Jenkins, K., Wright, S., and Burton, J.L. (1982) Reduced Levels of Prostaglandin Precursors in the Blood of Atopic Patients: Defective Δ6-Desaturase Function as a Biochemical Basis for Atopy, Prostaglandins Leukot. Med. 9, 615-628.
19. Bordoni, A., Biagi, P.L., Masi, M., Ricci, G., Fanelli, C., Patrizi, A., and Ceccolini, E. (1988) Evening Primrose Oil (Efamol) in the Treatment of Children with Atopic Eczema, Drugs Exp. Clin. Res. 14, 291-297.
20. Belch, J.J., and Hill, A. (2000) Evening Primrose Oil and Borage Oil in Rheumatologic Conditions, Am. J. Clin. Nutr. 71, 352S-356S.
21. Kremer, J.M. (2000) n-3 Fatty Acid Supplements in Rheumatoid Arthritis, Am. J. Clin. Nutr. 71, 349S-351S.
22. Yoshimoto-Furuie, K., Yoshimoto, K., Tanaka, T., Saima, S., Kikuchi, Y., Shay, J., Horrobin, D.F., and Echizen, H. (1999) Effects of Oral Supplementation with Evening Primrose Oil for Six Weeks on Plasma Essential Fatty Acids and Uremic Skin Symptoms in Hemodialysis Patients, Nephron 81, 151-159.
23. Peck, L.W. (1997) Essential Fatty Acid Deficiency in Renal Failure: Can Supplements Really Help? J. Am. Diet. Assoc. 97, S150-S153.
24. Peck, L.W., Monsen, E.R., and Ahmad, S. (1996) Effect of Three Sources of Long-Chain Fatty Acids on the Plasma Fatty Acid Profile, Plasma Prostaglandin E2 Concentrations, and Pruritus Symptoms in Hemodialysis Patients, Am. J. Clin. Nutr. 64, 210-214.
25. Carsons, S. (2001) A Review and Update of Sjogren's Syndrome: Manifestations, Diagnosis, and Treatment, Am. J. Manag. Care 7, S433-S443.
26. Oxholm, P., Asmussen, K., Wiik, A., and Horrobin, D.F. (1998) Essential Fatty Acid Status in Cell Membranes and Plasma of Patients with Primary Sjogren's Syndrome. Correlations to Clinical and Immunologic Variables Using a New Model for Classification and Assessment of Disease Manifestations, Prostaglandins Leukot. Essent. Fatty Acids 59, 239-245.
27. Strumia, R., Varotti, E., Manzato, E., and Gualandi, M. (2001) Skin Signs in Anorexia Nervosa, Dermatology 203, 314-317.
28. Marshman, G.M., Hanna, M.J., Ben-Tovim, D.I., and Walker, M.K. (1990) Cutaneous Abnormalities in Anorexia Nervosa, Australas J. Dermatol. 31, 9-12.
29. Schulze, U.M., Pettke-Rank, C.V., Kreienkamp, M., Hamm, H., Brocker, E.B., Wewetzer, C., Trott, G.E., and Warnke, A. (1999) Dermatologic Findings in Anorexia and Bulimia Nervosa of Childhood and Adolescence, Pediatr. Dermatol. 16, 90-94.
30. Richardson, A.J., Calvin, C.M., Clisby, C., Hall, J.A., Easton, T., McDaid, A.M., and Richardson, A.J. (2000) Fatty Acid Deficiency Signs Predict the Severity of Reading and Related Difficulties in Dyslexic Children, Prostaglandins Leukot. Essent. Fatty Acids 63, 69-74.
31. Taylor, K.E., Higgins, C.J., Calvin, C.M., Hall, J.A., Easton, T., McDaid, A.M., and Richardson, A.J. (2000) Dyslexia in Adults Is Associated with Clinical Signs of Fatty Acid Deficiency, Prostaglandins Leukot. Essent. Fatty Acids 63, 75-78.
32. Vancassel, S., Durand, G., Barthelemy, C., Lejeune, B., Martineau, J., Guilloteau, D., Andres, C., and Chalon, S. (2001) Plasma Fatty Acid Levels in Autistic Children, Prostaglandins Leukot. Essent. Fatty Acids 65, 1-7.
33. Terai, K., Munesue, T., and Hiratani, M. (1999) Excessive Water Drinking Behavior in Autism, Brain Dev. 21, 103-106.
34. Verghese, C., de Leon, J., and Josiassen, R.C. (1996) Problems and Progress in the Diagnosis and Treatment of Polydipsia and Hyponatremia, Schizophr. Bull. 22, 455-464.
35. de Leon, J., Tracy, J., McCann, E., and McGrory, A. (2002) Polydipsia and Schizophrenia in a Psychiatric Hospital: A Replication Study, Schizophr. Res. 57, 293-301.
36. Mercier-Guidez, E., and Loas, G. (2000) Polydipsia and Water Intoxication in 353 Psychiatric Inpatients: An Epidemiological and Psychopathological Study, Eur. Psychiatry 15, 306-311.
37. Holman, R.T., Adams, C.E., Nelson, R.A., Grater, S.J. Jaskiewicz, J.A., Johnson, S.B., and Erdman, J.W., Jr. (1995) Patients with Anorexia Nervosa Demonstrate Deficiencies of Selected Essential Fatty Acids, Compensatory Changes in Nonessential Fatty Acids and Decreased Fluidity of Plasma Lipids, J. Nutr. 125, 901-907.
38. Yoon, S., Lee, J., and Lee, S. (2002) The Therapeutic Effect of Evening Primrose Oil in Atopic Dermatitis Patients with Dry Scaly Skin Lesions Is Associated with the Normalization of Serum γ-Interferon Levels, Skin Pharmacol. Appl. Skin Physiol. 15, 20-25.
39. Rudin, D. (1981) The Major Psychoses and Neuroses as ω-3 Essential Fatty Acid Deficiency Syndrome: Substrate Pellagra, Biol. Psychiatry. 16, 837-850.
40. Stevens, L.J., Zentall, S.S., Deck, J.L., Abate, M.L., Watkins, B.A., Lipp, S.R., and Burgess, J.R. (1995) Essential Fatty Acid Metabolism in Boys with Attention-Deficit Hyperactivity Disorder, Am. J. Clin. Nutr. 62, 761-768.
41. Stevens, L., Zentall, S., Abate, M.L., Kuczek, T., and Burgess, J. (1996) Omega-3 Fatty Acids in Boys with Behavior, Learning, and Health Problems, Physiol. Behav. 59, 915-920.
42. Burgess, J., Stevens, L., Zhang, W., and Peck, L. (2000) Long-Chain Polyunsaturated Fatty Acids in Children with Attention-Deficit Hyperactivity Disorder, Am. J. Clin. Nutr. 71 (Suppl.), 327S-330S.
43. Yehuda, S., Rabinovitz, S., and Mostofsky, D.I. (1999) Essential Fatty Acids Are Mediators of Brain Biochemistry and Cognitive Functions, J. Neurosci. Res. 56, 565-570.
44. Reisbick, S., and Connor, W. (1985) n-3 Fatty Acids in the Brain and Retina: Evidence for Their Essentiality, Nutr. Rev. 44, 285-294.
45. Enslen, M., Milon, H., and Malnoe, A. (1991) Effect of Low Intake of n-3 Fatty Acids During the Development of Brain Phospholipid, Fatty Acid Composition and Exploratory Behavior in Rats, Lipids 26, 203-208.
46. Reisbick, S., Neuringer, M., Hasnain, R., and Connor, W. (1994) Home Cage Behavior of Rhesus Monkeys with Long-Term Deficiency of ω-3 Fatty Acids, Physiol. Behav. 55, 231-239.
47. Connor, W.E., and Neuringer, M. (1988) The Effects of n-3 Fatty Acid Deficiency and Repletion upon the Fatty Acid Composition and Function of the Brain and Retina, Prog. Clin. Biol. Res. 282, 275-294.
48. Hibbeln, J.R., and Salem, N., Jr. (1995) Dietary Polyunsaturated Fatty Acids and Depression: When Cholesterol Does Not Satisfy, Am. J. Clin. Nutr. 62, 1-9.
49. Adams, P.B., Lawson, S., Sanigorski, A., and Sinclair, A.J. (1996) Arachidonic Acid to Eicosapentaenoic Acid Ratio in Blood Correlates Positively with Clinical Symptoms of Depression, Lipids 31 (Suppl.), S157-S161.
50. Edwards, R., Peet, M., Shay, J., and Horrobin, D. (1998) Omega-3 Polyunsaturated Fatty Acid Levels in the Diet and in Red Blood Cell Membranes of Depressed Patients, J. Affect. Disord. 48, 149-155.
51. Stoll, A.L., Severus, W.E., Freeman, M.P., Rueter, S., Zboyan, H.A., Diamond, E., Cress, K.K., and Marangell, L.B. (1999) Omega 3 Fatty Acids in Bipolar Disorder: A Preliminary Double-Blind, Placebo-Controlled Trial, Arch. Gen. Psychiatry 56, 407-412.
52. Mellor, J.E., Laugharne, J.D., and Peet, M. (1996) Omega-3 Fatty Acid Supplementation in Schizophrenic Patients, Human Psychopharmacol. 11, 39-46.
53. Fenton, W.S., Dickerson, F., Boronow, J., Hibbeln, J.R., and Knable, M. (2001) A Placebo-Controlled Trial of ω-3 Fatty Acid (ethyl eicosapentaenoic acid) Supplementation for Residual Symptoms and Cognitive Impairment in Schizophrenia, Am. J. Psychiatry 158, 2071-2074.
54. Aman, M.G., Mitchell, E.A., and Turbott, S.H. (1987) The Effects of Essential Fatty Acid Supplementation by Efamol in Hyperactive Children, J. Abnorm. Child Psychol. 15, 75-90.
55. Richardson, A.J., and Puri, B.K. (2002) A Randomized Double-Blind, Placebo-Controlled Study of the Effects of Supplementation with Highly Unsaturated Fatty Acids on ADHD-Related Symptoms in Children with Specific Learning Difficulties, Prog. Neuropsychopharmacol. Biol. Psychiatry 26, 233-239.
56. Voigt, R.G., Llorente, A.M., Jensen, C.L., Fraley, J.K., Berretta, M.C., and Heird W.C. (2001) A Randomized, Double-Blind, Placebo-Controlled Trial of Docosahexaenoic Acid Supplementation in Children with Attention-Deficit/Hyperactivity Disorder, J. Pediatr. 139, 189-196.
57. Bligh, E., and Dyer, W. (1959) A Rapid Method of Total Lipid Extraction and Purification, Can. J. Biochem. Physiol. 37, 911-917.
58. Hamilton, J., and Comai, K. (1988) Rapid Separation of Neutral Lipids, Free Fatty Acids and Polar Lipids Using Prepacked Silica Sep-Pak Columns, Lipids 23, 1146-1149.
59. Watkins, B. (1988) Influences of Biotin Deficiency and Dietary trans-Fatty Acids on Tissue Lipids in Chicken, Br. J. Nutr. 61, 99-111.
60. Schuchardt, U., and Lopes, O.C. (1989) Tetramethylguanidine Catalyzed Transesterification of Fats and Oils: A New Method for Rapid Determination of Their Composition, J. Am. Oil Chem. Soc. 65, 1940-1941.
61. Kuo, C.F., Cheng, S., and Burgess, J.R. (1995) Deficiency of Vitamin E and Selenium Enhances Calcium-Independent Phospholipase A2 Activity in Rat Lung and Liver, J. Nutr. 125, 1419-1429.
62. Conners, C. (1990) Conners' Abbreviated Symptom Questionnaire, Multi-Health Systems, North Tonawanda, NY.
63. Satin, M., Winsberg, B., Monette, C., Sverd, J., and Foss, D. (1985) A General Population Screen for Attention Deficit Disorder with Hyperactivity, J. Am. Acad. Child Psychiatry 24, 756-764.
64. Parker, J., Sitarenios. G., and Conners, C. (1996) Abbreviated Conners' Rating Scales Revisited: A Confirmatory Factor Analytic Study, J. Atten. Disord. 1, 55-62.
65. Pelham, W.E., Jr., Gnagy, E.M., Greenslade, K.E., and Milich, R. (1992) Teacher Ratings of DSM-III-R Symptoms for the Disruptive Behavior Disorders, J. Am. Acad. Child Adolesc. Psychiatry 31, 210-218.
66. Conners, C.K. (1995) Conners' Continuous Performance Test Computer Program: User's Manual, Multi-Health Systems, Toronto, Ontario.
67. Woodcock, R., and Johnson, M. (1989) Woodcock-Johnson Psycho-Educational Battery-Revised (WJ-R), Riverside Publishing, Itasca, IL.
68. Halperin, J., Sharma, V., Greenblatt, E., and Schwartz, S. (1991) Assessment of the Continuous Performance Test: Reliability and Validity in a Nonreferred Sample, Psychol. Assess. 3, 603-608.
69. Conners, C.K., Eisenberg, L., and Barcai, A. (1967) Effect of Dextroamphetamine on Children. Studies on Subjects with Learning Disabilities and School Behavior Problems, Arch. Gen. Psychiatry 17, 478-485.
70. O'Toole, K., Abramowitz, A., Morris, R., and Dulcan, M. (1997) Effects of Methylphenidate on Attention and Nonverbal Learning in Children with Attention-Deficit Hyperactivity Disorder, J. Am. Acad. Child Adolesc. Psychiatry 36, 531-538.
71. Woodcock, R. (1990) Theoretical Foundations of the WJ-R Measures of Cognitive Ability, J. Psychoeducational Assess. 8, 231-258.
72. Wainwright, P. (1993) Lipids and Behavior: The Evidence from Animal Models, in Lipids, Learning and the Brain: Fats in Infant Formulas (Dobbing, J., ed.), Ross Laboratories, Adelaide, S. Australia.
73. Neuringer, M., Reisbick, S., and Janowsky, J. (1994) The Role of n-3 Fatty Acids in Visual and Cognitive Development: Current Evidence and Methods of Assessment, J. Pediatr. 125, S39-S47.
74. Gillings, D., and Koch, G. (1991) The Application of the Principle of Intention-to-Treat to the Analysis of Clinical Trials, Drug Inf. J. 25, 411-424.
75. Mazumdar, S., Liu, K.S., Houck, P.R., and Reynolds, C.F., III (1999) Intent-to-Treat Analysis for Longitudinal Clinical Trials: Coping with the Challenge of Missing Values, J. Psychiatr. Res. 33, 87-95.
76. Conners, C.K. (1990) Conners' Rating Scale Manual, MultiHealth Systems, Toronto, Ontario.
77. Urban, M., Filipczuk-Maslowiecka, J., Grojec, M., Krawczuk-Rybakowa, M., Pedzinski, W., and Niewiarowska, A. (1984) Composition of Serum Fatty Acids in Healthy Children, Acta Physiol. Pol. 35, 93-100.
78. Holman, R. (1981) Polyunsaturated Fatty Acid Profiles in Human Disease, in New Trends in Nutrition, Lipid Research, and Cardiovascular Diseases (Bazan, N.G., Paoletti, R., and Iacono, J.M., eds.), pp. 25-42, Alan R. Liss, New York.
79. Decsi, T., and Koletzko, B. (1994) Fatty Acid Composition of Plasma Lipid Classes in Healthy Subjects from Birth to Young Adulthood, Eur. J. Pediatr. 153, 520-525.
80. Mitchell, E.A., Lewis, S., and Cutler, D.R. (1983) Essential Fatty Acids and Maladjusted Behaviour in Children, Prostaglandins Leukot. Med. 12, 281-287.
81. Lands, W.E., Libelt, B., Morris, A., Kramer, N.C., Prewitt, T.E., Bowen, P., Schmeisser, D., Davidson, M.H., and Burns, J.H. (1992) Maintenance of Lower Proportions of (n-6) Eicosanoid Precursors in Phospholipids of Human Plasma in Response to Added Dietary (n-3) Fatty Acids, Biochim. Biophys. Acta 1180, 147-162.
82. Salem, N., Jr., Litman, B., Kim, H.Y., and Gawrisch, K. (2001) Mechanisms of Action of Docosahexaenoic Acid in the Nervous System, Lipids 36, 945-959.
83. Mohrhauer, H., and Holman, R.T. (1963) Alteration of the Fatty Acid Composition of Brain Lipids by Varying Levels of Dietary Essential Fatty Acids, J. Neurochem. 10, 523-530.
84. Baur, L.A., O'Connor, J., Pan, D.A., Wu, B.J., O'Connor, M.J., and Storlien, L.H. (2000) Relationships Between the Fatty Acid Composition of Muscle and Erythrocyte Membrane Phospholipid in Young Children and the Effect of Type of Infant Feeding, Lipids 35, 77-82.
85. Carver, J.D., Benford, V.J., Han, B., and Cantor, A.B. (2001) The Relationship Between Age and the Fatty Acid Composition of Cerebral Cortex and Erythrocytes in Human Subjects, Brain Res. Bull. 56, 79-85.
86. Vognild, E., Elvevoll, E.O., Brox, J., Olsen, R.L., Barstad, H., Aursand, M., and Osterud, B. (1998) Effects of Dietary Marine Oils and Olive Oil on Fatty Acid Composition, Platelet Membrane Fluidity, Platelet Responses, and Serum Lipids in Healthy Humans, Lipids 33, 427-436.
87. Innis, S.M., Auestad, N., and Siegman, J.S. (1996) Blood Lipid Docosahexaenoic and Arachidonic Acid in Term Gestation Infants Fed Formulas with High Docosahexaenoic Acid, Low Eicosapentaenoic Acid Fish Oil, Lipids 31, 617-625.
88. Whelan, J. (1996) Antagonistic Effects of Dietary Arachidonic Acid and n-3 Polyunsaturated Fatty Acids, J. Nutr. 126, 1086S-1091S.
89. Blonk, M.C., Bilo, H.J., Nauta, J.J., Popp-Snijders, C., Mulder, C., and Donker, A.J. (1990) Dose-Response Effects of Fish-Oil Supplementation in Healthy Volunteers, Am. J. Clin. Nutr. 52, 120-127.
90. Belzung, C., Leguisquet, A.M., Barreau, S., Delion-Vancassel, S., Chalon, S., and Durand, G. (1998) α-Linolenic Acid Deficiency Modifies Distractibility but Not Anxiety and Locomotion in Rats During Aging, J. Nutr. 128, 1537-1542.
91. Zimmer, L., Delion-Vancassel, S., Durand, G., Guilloteau, D., Bodard, S., Besnard, J.C., and Chalon, S. (2000) Modification of Dopamine Neurotransmission in the Nucleus Accumbens of Rats Deficient in n-3 Polyunsaturated Fatty Acids, J. Lipid Res. 41, 32-40.
92. Yamamoto, N., Hashimoto, A., Takemoto, Y., Okuyama, H., Nomura, M., Kitajima, R., Togashi, T., and Tamai, Y. (1988) Effect of the Dietary α-Linolenate/Linoleate Balance on Lipid Composition and Learning Ability of Rats, J. Lipid Res. 29, 1013-1021.
93. Wainwright, P.E., Huang, Y.S., Coscina, D.V., Levesque, S., and McCutcheon, D. (1994) Brain and Behavioral Effects of Dietary n-3 Deficiency in Mice: A Three-Generational Study, Dev. Psychobiol. 27, 467-487.
94. Reisbick, S., Neuringer, M., Gohl, E., Wald, R., and Anderson, G.J. (1997) Visual Attention in Infant Monkeys: Effects of Dietary Fatty Acids and Age, Dev. Psychol. 33, 387-395.
95. Gesch, C.B., Hammond, S.M., Hampson, S.E., Eves, A., and Crowder, M.J. (2002) Influence of Supplementary Vitamins, Minerals and Essential Fatty Acids on the Antisocial Behaviour of Young Adult Prisoners. Randomised, Placebo-Controlled Trial, Br. J. Psychiatry 181, 22-28.
96. Sawazaki, S., Hamazaki, T., Yazawa, K., and Kobayashi, M. (1999) The Effect of Docosahexaenoic Acid on Plasma Catecholamine Concentrations and Glucose Tolerance During Long-Lasting Psychological Stress: A Double-Blind Placebo-Controlled Study, J. Nutr. Sci. Vitaminol. (Tokyo) 45, 655-665.
97. Hamazaki, T., Sawazaki, S., Itomura, M., Asaoka, E., Nagao, Y., Nishimura, N., Yazawa, K., Kuwamori, T., and Kobayashi, M. (1996) The Effect of Docosahexaenoic Acid on Aggression in Young Adults. A Placebo-Controlled Double-Blind Study, J. Clin. Invest. 97, 1129-1133.
98. Arvindakshan, M., Ghate, M., Ranjekar, P.K., Evans, D.R., and Mahadik, S.P. (2003) Supplementation with a Combination of ω-3 Fatty Acids and Antioxidants (vitamins E and C) Improves the Outcome of Schizophrenia, Schizophr. Res. 62, 195-204.
99. Wolraich, M.L., Lindgren, S., Stromquist, A., Milich, R., Davis, C., and Watson, D. (1990) Stimulant Medication Use by Primary Care Physicians in the Treatment of Attention Deficit Hyperactivity Disorder, Pediatrics 86, 95-101.
100. Peet, M., and Horrobin, D.F. (2002) A Dose-Ranging Exploratory Study of the Effects of Ethyl-Eicosapentaenoate in Patients with Persistent Schizophrenic Symptoms, J. Psychiatr. Res. 36, 7-18.